Vetoquinol SA (EPA:VETO)
France flag France · Delayed Price · Currency is EUR
78.30
0.00 (0.00%)
At close: Mar 13, 2026

Vetoquinol Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
9248861,2121,0361,561989
Market Cap Growth
7.22%-26.85%16.92%-33.62%57.82%29.72%
Enterprise Value
7607441,1281,0131,545897
Last Close Price
78.3074.01100.3685.07127.3280.27
PE Ratio
15.3615.1021.8121.5924.8351.46
Forward PE
14.8215.4220.7517.0123.8223.76
PS Ratio
1.731.642.291.923.002.31
PB Ratio
1.631.542.302.143.542.66
P/TBV Ratio
2.562.484.074.328.718.46
P/FCF Ratio
17.3312.4316.2622.5820.5712.08
P/OCF Ratio
13.0310.3313.5516.4917.4010.73
PEG Ratio
-5.435.435.435.432.49
EV/Sales Ratio
1.431.382.131.882.962.10
EV/EBITDA Ratio
6.887.5310.779.3414.3611.84
EV/EBIT Ratio
9.509.7314.4611.9918.9015.93
EV/FCF Ratio
14.2610.4415.1422.0720.3610.96
Debt / Equity Ratio
0.030.040.030.040.040.34
Debt / EBITDA Ratio
0.160.200.160.150.141.55
Debt / FCF Ratio
0.330.300.240.380.201.53
Net Debt / Equity Ratio
-0.29-0.32-0.25-0.16-0.12-0.01
Net Debt / EBITDA Ratio
-1.57-1.87-1.24-0.70-0.50-0.06
Net Debt / FCF Ratio
-3.07-2.60-1.74-1.66-0.71-0.06
Asset Turnover
0.740.750.790.850.820.74
Inventory Turnover
1.792.222.172.122.322.38
Quick Ratio
2.092.131.811.310.990.91
Current Ratio
3.112.982.612.191.741.28
Return on Equity (ROE)
10.79%10.64%10.98%10.37%15.46%5.08%
Return on Assets (ROA)
6.98%6.66%7.26%8.27%8.04%6.08%
Return on Invested Capital (ROIC)
14.51%14.07%13.99%13.99%15.71%8.88%
Return on Capital Employed (ROCE)
13.50%12.70%14.10%16.50%17.50%13.90%
Earnings Yield
6.49%6.62%4.59%4.63%4.03%1.94%
FCF Yield
5.77%8.04%6.15%4.43%4.86%8.28%
Dividend Yield
1.14%1.20%0.85%0.94%0.63%0.62%
Payout Ratio
17.35%17.14%17.04%19.72%9.41%23.38%
Buyback Yield / Dilution
0.58%0.31%-0.01%-0.03%0.03%0.00%
Total Shareholder Return
1.72%1.51%0.84%0.91%0.66%0.62%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.